会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Device for local and/or regional delivery employing liquid formulations of therapeutic agents
    • 用于局部和/或区域递送的装置,其使用治疗剂的液体制剂
    • US08557272B2
    • 2013-10-15
    • US13086514
    • 2011-04-14
    • Jonathon Z. Zhao
    • Jonathon Z. Zhao
    • A61F2/00A61L31/16
    • A61L31/16A61K31/337A61K31/4355A61K31/436A61K31/4745A61L29/16A61L2300/416A61L2300/428A61L2300/802
    • Medical devices may be utilized for local and regional therapeutic agent delivery. These therapeutic agents or compounds may reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the prevention of thrombosis. The drugs, agents, and/or compounds may also be utilized to treat specific disorders, including restenosis, vulnerable plaque, and atherosclerosis in type 2 diabetic patients. In regional delivery, liquid formulations may be desirable to increase the efficacy and deliverability of the particular drug. Various materials and coating methodologies may be utilized to maintain the agents or compounds on the medical device until delivered and positioned.
    • 医疗器械可用于局部和区域治疗剂递送。 这些治疗剂或化合物可以减少生物体对将生物体引入医疗装置的反应。 此外,这些治疗药物,药剂和/或化合物可用于促进愈合,包括预防血栓形成。 药物,药剂和/或化合物也可用于治疗2型糖尿病患者中的特定疾病,包括再狭窄,易损斑块和动脉粥样硬化。 在区域递送中,液体制剂可能是期望的,以增加特定药物的功效和递送能力。 可以使用各种材料和涂覆方法来将药剂或化合物维持在医疗装置上,直到被输送和定位。
    • 4. 发明申请
    • COATING FOR A MEDICAL DEVICE HAVING AN ANTI-THROMBOTIC CONJUGATE
    • 用于具有抗凝血药物的医疗装置的涂层
    • US20130172986A1
    • 2013-07-04
    • US13751997
    • 2013-01-28
    • Jonathon Z. Zhao
    • Jonathon Z. Zhao
    • A61F2/00C09D133/14
    • A61F2/0077A61F2/91A61F2250/0068A61L31/10A61L31/16A61L33/08A61L2300/42C09D133/14C08L67/04C08L29/04C08L5/10
    • An implantable device having a coating comprising a comb-type anti-thrombotic conjugate to prevent or reduce the formation of thrombosis on the surface of the device. The device includes a frame expandable from a first diameter to a second diameter wherein the frame has an inner surface and an outer surface, a plurality of structural features disposed along the frame and a plurality of polymer anti-thrombotic conjugate particles situated with the plurality of structural features. The particle can be created utilizing the comb type polymer and heparin conjugate as a carrier for a therapeutic agent within its polymer matrix. The structural features allow for particles having differing properties to be placed at various locations along the device. Moreover, particles having at least two different agents can be located within the same structural feature.
    • 一种可植入装置,其具有包含梳状抗血栓形成共轭物的涂层,以防止或减少装置表面上的血栓形成。 该装置包括可从第一直径扩展到第二直径的框架,其中框架具有内表面和外表面,沿着框架设置的多个结构特征以及多个聚合物抗血栓形成共轭物颗粒, 结构特征。 可以使用梳型聚合物和肝素缀合物作为其聚合物基质内的治疗剂的载体来产生颗粒。 结构特征允许具有不同性质的颗粒放置在沿设备的各个位置。 此外,具有至少两种不同试剂的颗粒可以位于相同的结构特征内。
    • 5. 发明授权
    • Coating for a medical device having an anti-thrombotic conjugate
    • 具有抗血栓形成缀合物的医疗装置的涂层
    • US08383156B2
    • 2013-02-26
    • US11741997
    • 2007-04-30
    • Jonathon Z. Zhao
    • Jonathon Z. Zhao
    • A61K9/14A61K31/74
    • A61F2/0077A61F2/91A61F2250/0068A61L31/10A61L31/16A61L33/08A61L2300/42C09D133/14C08L67/04C08L29/04C08L5/10
    • Methods for making comb-type antithrombotic conjugate wherein substantially all side chains of water soluble poly(vinyl alcohol) (PVA) are extended by ring-opening polymerization to form a copolymer wherein substantially all terminals are conjugated to an antithrombotic molecule. In addition, a method is provided for applying a coating comprising a comb-type anti-thrombotic conjugate to at least a portion of an implantable device to prevent or reduce the formation of thrombosis on the surface of the device. A first or sub-layer of the coating is prepared by mixing a polymeric material and a biologically active agent with a solvent, thereby forming a homogeneous solution. A second or outer layer comprising a comb-type anti-thrombotic conjugate may be applied over the inner drug-containing layers using, for example, a dip coating or spray coating process. Alternatively the comb-type antithrombotic conjugate may be used as a matrix material to encapsulate a pharmaceutical agent to form microspheres or nanospheres before depositing the microspheres or nanospheres onto a medical device.
    • 制备梳状抗血栓缀合物的方法,其中水溶性聚(乙烯醇)(PVA)的基本上所有侧链通过开环聚合延伸以形成基本上所有末端与抗血栓形成分子缀合的共聚物。 此外,提供了一种用于将包含梳型抗血栓形成结合物的涂层施用于可植入装置的至少一部分以防止或减少装置表面上形成血栓形成的方法。 通过将聚合材料和生物活性剂与溶剂混合制备涂层的第一层或次层,由此形成均匀溶液。 可以使用例如浸涂或喷涂方法将包含梳型抗血栓形成缀合物的第二层或外层涂覆在内含药物层上。 或者,梳状抗血栓缀合物可以用作基质材料,以在将微球或纳米球沉积到医疗装置上之前封装药剂以形成微球或纳米球。
    • 8. 发明申请
    • INJECTABLE FORMULATIONS OF TAXANES FOR CAD TREATMENT
    • US20110245332A1
    • 2011-10-06
    • US13158610
    • 2011-06-13
    • Robert FaloticoJonathon Z. Zhao
    • Robert FaloticoJonathon Z. Zhao
    • A61K31/337A61P9/00
    • A61K9/0019A61K9/19A61K31/337A61K47/22
    • Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the formation of blood clots. The drugs, agents, and/or compounds may also be utilized to treat specific diseases, including vulnerable plaque. Therapeutic agents may also be delivered to the region of a disease site. In regional delivery, liquid formulations may be desirable to increase the efficacy and deliverability of the particular drug. Also, the devices may be modified to promote endothelialization. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned. In addition, the devices utilized to deliver the implantable medical devices may be modified to reduce the potential for damaging the implantable medical device during deployment. Medical devices include stents, grafts, anastomotic devices, perivascular wraps, sutures and staples. In addition, various polymer combinations may be utilized to control the elution rates of the therapeutic drugs, agents and/or compounds from the implantable medical devices. Liquid formulations, including solutions and suspensions of the various drugs, agents and/or compounds, may be locally or regionally delivered. In each of these instances, antioxidants are utilized to prolong product integrity.